U.S. coronavirus cases eclipse 20 million
The 20 millionth case comes less than two months after the country tallied its 10 millionth.
The 20 millionth case comes less than two months after the country tallied its 10 millionth.
The 20 millionth case comes less than two months after the country tallied its 10 millionth.
The 20 millionth case comes less than two months after the country tallied its 10 millionth.
The 20 millionth case comes less than two months after the country tallied its 10 millionth.
The FDA is expected to authorize additional over-the-counter Covid-19 tests in the coming weeks that could bolster supply.
The nation’s testing capacity has increased, but not fast enough to keep pace with the swarm of new cases.
The nation’s testing capacity has increased, but not fast enough to keep pace with the swarm of new cases.
The nation’s testing capacity has increased, but not fast enough to keep pace with the swarm of new cases.
The nation’s testing capacity has increased, but not fast enough to keep pace with the swarm of new cases.
The nation’s testing capacity has increased, but not fast enough to keep pace with the swarm of new cases.
The nation’s testing capacity has increased, but not fast enough to keep pace with the swarm of new cases.
The nation’s testing capacity has increased, but not fast enough to keep pace with the swarm of new cases.
The latest surge comes ahead of what’s expected to be an especially dangerous winter for the virus, with hospitalizations already on the rise.
The latest surge comes ahead of what’s expected to be an especially dangerous winter for the virus, with hospitalizations already on the rise.
The latest surge comes ahead of what’s expected to be an especially dangerous winter for the virus, with hospitalizations already on the rise.
The latest surge comes ahead of what’s expected to be an especially dangerous winter for the virus, with hospitalizations already on the rise.
Concerns about the tests’ reliability, how consumers might react to their results and how public health departments will track them have slowed development.
The latest surge comes ahead of what’s expected to be an especially dangerous winter for the virus, with hospitalizations already on the rise.
Concerns about the tests’ reliability, how consumers might react to their results and how public health departments will track them have slowed development.
The latest surge comes ahead of what’s expected to be an especially dangerous winter for the virus, with hospitalizations already on the rise.
Concerns about the tests’ reliability, how consumers might react to their results and how public health departments will track them have slowed development.
The latest surge comes ahead of what’s expected to be an especially dangerous winter for the virus, with hospitalizations already on the rise.
Concerns about the tests’ reliability, how consumers might react to their results and how public health departments will track them have slowed development.
The latest surge comes ahead of what’s expected to be an especially dangerous winter for the virus, with hospitalizations already on the rise.
Concerns about the tests’ reliability, how consumers might react to their results and how public health departments will track them have slowed development.
The latest surge comes ahead of what’s expected to be an especially dangerous winter for the virus, with hospitalizations already on the rise.
Concerns about the tests’ reliability, how consumers might react to their results and how public health departments will track them have slowed development.
The latest surge comes ahead of what’s expected to be an especially dangerous winter for the virus, with hospitalizations already on the rise.
Concerns about the tests’ reliability, how consumers might react to their results and how public health departments will track them have slowed development.
Concerns about the tests’ reliability, how consumers might react to their results and how public health departments will track them have slowed development.